​

Alaunos Therapeutics Ownership | Who Owns Alaunos Therapeutics?

OverviewForecastRevenueFinancialsChart

Alaunos Therapeutics Ownership Summary

Alaunos Therapeutics is owned by 15.18% institutional investors, 5.98% insiders, and 78.84% retail investors. Eversource wealth advisors is the largest institutional shareholder, holding 0% of TCRT shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 1.56% of its assets in Alaunos Therapeutics shares.

TCRT Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAlaunos Therapeutics15.18%5.98%78.84%
SectorHealthcare Stocks 278.45%10.60%-189.04%
IndustryBiotech Stocks 63.84%10.66%25.50%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Eversource wealth advisors---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Eversource wealth advisors---

Top Buyers

HolderShares% AssetsChange
Eversource wealth advisors---40.00

Top Sellers

HolderShares% AssetsChange
Eversource wealth advisors---40.00

Sold Out

HolderChange
Eversource wealth advisors-40.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202447-2,430,2983.47%157.05%1344.44%11-69.44%
Mar 31, 20241-98.80%40-100.00%----100.00%--100.00%
Dec 31, 202383-9.78%41,174,501-26.49%173.14%17-27-3.57%
Sep 30, 202392-14.02%56,012,255-16.44%232.99%17-37.04%2816.67%
Jun 30, 2023107-7.76%67,033,956-5.32%273.21%27-6.90%24-22.58%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard US Total Market Shares ETF24.91K1.56%-15.49K
Vanguard Institutional Extnd Mkt Idx Tr20.47K1.25%-
Vanguard Total Stock Mkt Idx Inv17.35K1.08%-7.03K
Fidelity Extended Market Index9.21K0.56%-54.00
BlackRock Extended Equity Market K2.98K0.19%-2.00
Extended Equity Market Fund K2.95K0.18%9.00
Fidelity Total Market Index2.38K0.14%-
Fidelity Series Total Market Index2.08K0.13%-
NT Ext Equity Mkt Idx Fd - L1.36K0.08%-
Northern Trust Extended Eq Market Idx1.36K0.08%-

Recent Insider Transactions

DateNameRoleActivityValue
Jun 24, 2025Vieser Jaime-Buy$1.12K
Jun 24, 2025Postma Robert W-Buy$2.69K
Apr 11, 2025Postma Robert W-Buy$1.38K
Dec 31, 2024Vieser Jaime-Sell$4.39K
Dec 31, 2024Vieser Jaime-Sell$1.64K

Insider Transactions Trends

DateBuySell
2024 Q3--
2024 Q2--
2024 Q1--
2023 Q4--
2023 Q3-1

TCRT Ownership FAQ

Who Owns Alaunos Therapeutics?

Alaunos Therapeutics shareholders are primarily institutional investors at 15.18%, followed by 5.98% insiders and 78.84% retail investors. The average institutional ownership in Alaunos Therapeutics's industry, Biotech Stocks , is 63.84%, which Alaunos Therapeutics falls below.

Does Blackrock own Alaunos Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Alaunos Therapeutics.

Who is Alaunos Therapeutics’s biggest shareholder by percentage of total assets invested?

Eversource wealth advisors is Alaunos Therapeutics’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Alaunos Therapeutics shares, valued at 0$.

Who is the top mutual fund holder of Alaunos Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Alaunos Therapeutics shares, with 1.56% of its total shares outstanding invested in 24.91K Alaunos Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools